Table 1 (abstract P037). Clinical characteristics among biologic switchers and non-switchers in juvenile idiopathic arthritis (JIA)

N

74

126

Male

17 (23)

40 (32)

0.185

Female

57 (77)

86 (68)

 - Persistent Oligo

10 (13.5)

16 (13)

0.549

 - Extended Oligo

27 (36.5)

34 (27)

 - RF+ Polyarticular JIA

2 (3)

6 (5)

 - RF- Polyarticular JIA

23 (31)

36 (29)

 - Psoriatic

4 (5)

9 (7)

 - ERA

5 (7)

19 (15)

ERA: 0.08

 - Undifferentiated

3 (4)

6 (5)

 ETN

49 (66)

50 (40)

Enbrel vs Benepali:

 Enbrel

36 (73)

35 (70)

0.911

 Benepali

13 (27)

12 (24)

 Erelzi

0

3 (6)

ETN vs ADA:

<0.001

ADA

15 (20)

61 (48)

GOL

4 (6)

14 (11)

IFX

6 (8)

1 (1)

Disease duration (years)

7.3 (4.7-10.6)

5.4 (3.5-9.0)

0.017

Active joints at start of 1^st biologic

2 (1-4)

2 (1-4)

0.987

Cumulative joints at start of 1^st biologic

3 (1-8)

6 (4.25-10)

<0.001

DMARD before 1^st biologic

69 (93)

107 (85)

0.042

DMARD plus 1^st biologic

55 (74)

102 (81)

0.128